What is the price of Vemurafenib in China after medical insurance?

Vemurafenib (Vemurafenib) is used to treat melanoma (skin cancer) that has spread to other parts of the body or cannot be removed with surgery. Vemurafenib is also used to treat Erdheim-Chester disease, a rare blood cancer. The original drug of vemurafenib has been marketed in China and has entered the scope of Class B medical insurance, but only for BRAF determined by testing methods approved by the CFDA. Patients with V600 mutation-positive unresectable or metastatic melanoma are reimbursed. SpecificationsThe price of 240mg*56 tablets per box may be around 7,000 yuan. Reimbursement is different in different regions of the country, and the price after reimbursement may be different. Patients can consult at local medical insurance bureaus or hospitals.